MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug head off multiple myeloma before it starts?
Disease control Recruiting nowThis study tests an investigational drug called linvoseltamab in people with two precancerous conditions—high-risk MGUS and non-high-risk smoldering multiple myeloma—that raise the risk of developing multiple myeloma. The goal is to see if the drug can eliminate abnormal plasma c…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:09 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to find multiple myeloma at its earliest, precancerous stage (MGUS) in people at higher risk—Black adults and those with a family history of plasma cell disorders. By screening with a simple blood test, researchers hope to catch the disease before it causes seriou…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC
-
New study aims to predict who will develop multiple myeloma
Knowledge-focused Recruiting nowThis observational study is looking for biological markers that can predict if early blood disorders (MGUS or SMM) will progress to multiple myeloma, a type of blood cancer. Researchers will analyze genetics, immune cells, and mouth bacteria from 60 patients and compare them to h…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 01:59 UTC
-
Massive study seeks genetic clues in early blood cancers
Knowledge-focused Recruiting nowThis study aims to find genetic changes in people with early-stage blood cancers or conditions that may lead to cancer. Researchers will analyze blood, bone marrow, or tissue samples from up to 10,000 participants to understand how these changes cause cancer to progress. The goal…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 01:50 UTC